12:00 AM
 | 
Jan 17, 2000
 |  BC Week In Review  |  Company News  |  Deals

Valentis, Eli Lilly deal

VLTS said that due to delays in preclinical work at its contract laboratory, VLTS and LLY...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >